We are live on ! Find out more
NVRO

NEVRO CORP.

Delisted

NVRO was delisted on the 2nd of April, 2025.

172 hedge funds and large institutions have $2B invested in NEVRO CORP. in 2019 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 49 increasing their positions, 49 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding in top 10

Funds holding in top 10: 14 (+3)

64% more capital invested

Capital invested by funds: $1.22B → $2B (+$779M)

45% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 33

10% more funds holding

Funds holding: 157172 (+15)

0% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 49

14% less call options, than puts

Call options by funds: $25.1M | Put options by funds: $29.1M

Holders
172
Holders Change
+15
Holders Change %
+9.55%
% of All Funds
3.72%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.09%
New
48
Increased
49
Reduced
49
Closed
33
Calls
$25.1M
Puts
$29.1M
Net Calls
-$3.94M
Net Calls Change
-$17.9M
Name Holding Trade Value Shares
Change
Change in
Stake
AGA
76
Altrinsic Global Advisors
Connecticut
$1.88M -$235K -5,000 -14%
CM
77
Caption Management
Oklahoma
$1.88M +$1.41M +30,000 New
Allianz Asset Management
78
Allianz Asset Management
Germany
$1.71M -$456K -9,701 -26%
UCFA
79
United Capital Financial Advisors
Texas
$1.67M
JRP
80
Jasper Ridge Partners
California
$1.63M
AAMU
81
Amundi Asset Management US
Massachusetts
$1.52M +$1.15M +24,400 New
CI
82
Cambiar Investors
Colorado
$1.41M +$1.06M +22,575 New
TI
83
Trexquant Investment
Connecticut
$1.41M -$119K -2,536 -10%
UBS AM
84
UBS AM
Illinois
$1.28M +$493K +10,474 +105%
DWT
85
Dorsey & Whitney Trust
South Dakota
$1.25M
CSS
86
Cubist Systematic Strategies
Connecticut
$1.21M -$708K -15,061 -44%
GI
87
GAMCO Investors
Connecticut
$1.2M -$47K -1,000 -5%
AIG
88
American International Group
New York
$1.16M -$28.3K -602 -3%
Los Angeles Capital Management
89
Los Angeles Capital Management
California
$1.06M -$916K -19,487 -53%
Man Group
90
Man Group
United Kingdom
$1.02M -$643K -13,668 -46%
State Board of Administration of Florida Retirement System
91
State Board of Administration of Florida Retirement System
Florida
$980K
MAP
92
Moody Aldrich Partners
Massachusetts
$970K +$730K +15,525 New
AIM
93
Assured Investment Management
New York
$964K +$725K +15,422 New
WMSA
94
Weiss Multi-Strategy Advisers
New York
$938K +$705K +15,000 New
LCG
95
Lisanti Capital Growth
New York
$839K +$631K +13,415 New
MIM
96
MetLife Investment Management
New Jersey
$815K
Legal & General Group
97
Legal & General Group
United Kingdom
$813K +$5.6K +119 +0.9%
VOYA Investment Management
98
VOYA Investment Management
Georgia
$747K -$9.5K -202 -2%
Envestnet Asset Management
99
Envestnet Asset Management
Illinois
$698K +$166K +3,521 +46%
Balyasny Asset Management
100
Balyasny Asset Management
Illinois
$694K -$7.23M -153,731 -93%

NVRO Hedge Fund Activity: Q1 2019 in Review

172 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q1 2019, worth a combined $2B — up 64% from $1.22B a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new NVRO positions and 33 closed out — a net gain of 15 holders — while 49 added to existing stakes and 49 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $29.2M. The largest seller was Point72 Asset Management, cutting an estimated $50.9M.

  • 172 institutional investors held NEVRO CORP. (NVRO) as of Q1 2019, up from 157 in Q4 2018.
  • Funds reported $2B of NEVRO CORP. stock for Q1 2019, up 64% quarter-over-quarter.
  • 48 funds opened new NEVRO CORP. positions in Q1 2019 and 33 closed out, a net change of +15 holders.
  • The largest NEVRO CORP. buyer in Q1 2019 was T. Rowe Price Associates, an estimated $29.2M added.
  • The largest NEVRO CORP. seller in Q1 2019 was Point72 Asset Management, an estimated $50.9M sold.

Based on aggregated 13F filings for Q1 2019.